Cargando…
Stereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours
Stereotactic ablative body radiotherapy (SABR) represents a technological breakthrough in radiotherapy technique, with proven benefits to patients in terms of improved tumour control and overall survival. The key components of SABR are described. The current evidence base for SABR for the treatment...
Autores principales: | Goldsmith, Christy, Gaya, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
e-Med
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460596/ https://www.ncbi.nlm.nih.gov/pubmed/23023165 http://dx.doi.org/10.1102/1470-7330.2012.9015 |
Ejemplares similares
-
Ablation of lung tumours
por: Gillams, Alice
Publicado: (2012) -
Tumour ablation: current role in the kidney, lung and bone
por: Gillams, Alice
Publicado: (2009) -
Tumour ablation: technical aspects
por: Widmann, Gerlig, et al.
Publicado: (2009) -
Optimal and actual rates of Stereotactic Ablative Body Radiotherapy (SABR) utilisation for primary lung cancer in Australia
por: Ghandourh, Wsam, et al.
Publicado: (2022) -
Technical know‐how in stereotactic ablative radiotherapy (SABR)
por: Lo, Simon S., et al.
Publicado: (2016)